Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Alessi

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
Thrombosis and Haemostasis|February 3, 1987
Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosisI Juhan-Vague, J Valadier, M C Alessi, et al.
Journal of Thrombosis and Haemostasis : JTH|September 13, 2007
Chronic plasminogen activator inhibitor-1 (PAI-1) overexpression dampens CD25+ lymphocyte recruitment after lipopolysaccharide endotoxemia in mouse lungM Poggi, O Paulmyer-Lacroix, M Verdier, et al.
La Revue De Medecine Interne|January 31, 2002
[Acquired factor V inhibitor: etiology, bleeding risk and therapeutic management with regard to three cases]N Schleinitz, V Veit, D Chouquet, et al.
The Journal of Biological Chemistry|October 25, 1988
Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin)P J Declerck, M De Mol, M C Alessi, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1990
Modulation of tPA, PAI-1 and PAI-2 antigen and mRNA levels by EGF in the A431 cell lineF George, N Pourreau-Schneider, D Arnoux, et al.
Annales De Cardiologie Et D'Angeiologie|May 28, 2014
Safety and effectiveness of the association ezetimibe-statin (E-S) versus high dose rosuvastatin after acute coronary syndrome: the SAFE-ES studyP Deharo, M Pankert, J Quilici, et al.
Diabetes|April 2, 1999
Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissueP E Morange, J Aubert, F Peiretti, et al.
Presse Medicale (Paris, France : 1983)|December 7, 1985
[Thromboembolic risk remains uncertain in protein C deficiency]M F Aillaud, J R Harle, C Guidon, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 5, 2017
Peripartum bleeding management in a patient with CalDAG-GEFI deficiencyM Canault, P Saultier, S Fauré, et al.
British Journal of Haematology|December 21, 2004
Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohortP E Morange, D A Tregouet, C Frere, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
Thrombosis and Haemostasis|February 3, 1987
Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosisI Juhan-Vague, J Valadier, M C Alessi, et al.
Journal of Thrombosis and Haemostasis : JTH|September 13, 2007
Chronic plasminogen activator inhibitor-1 (PAI-1) overexpression dampens CD25+ lymphocyte recruitment after lipopolysaccharide endotoxemia in mouse lungM Poggi, O Paulmyer-Lacroix, M Verdier, et al.
La Revue De Medecine Interne|January 31, 2002
[Acquired factor V inhibitor: etiology, bleeding risk and therapeutic management with regard to three cases]N Schleinitz, V Veit, D Chouquet, et al.
The Journal of Biological Chemistry|October 25, 1988
Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin)P J Declerck, M De Mol, M C Alessi, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1990
Modulation of tPA, PAI-1 and PAI-2 antigen and mRNA levels by EGF in the A431 cell lineF George, N Pourreau-Schneider, D Arnoux, et al.
Annales De Cardiologie Et D'Angeiologie|May 28, 2014
Safety and effectiveness of the association ezetimibe-statin (E-S) versus high dose rosuvastatin after acute coronary syndrome: the SAFE-ES studyP Deharo, M Pankert, J Quilici, et al.
Diabetes|April 2, 1999
Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissueP E Morange, J Aubert, F Peiretti, et al.
Presse Medicale (Paris, France : 1983)|December 7, 1985
[Thromboembolic risk remains uncertain in protein C deficiency]M F Aillaud, J R Harle, C Guidon, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 5, 2017
Peripartum bleeding management in a patient with CalDAG-GEFI deficiencyM Canault, P Saultier, S Fauré, et al.
British Journal of Haematology|December 21, 2004
Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohortP E Morange, D A Tregouet, C Frere, et al.
Pageof 15